Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative ...

Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...

Tolebrutinib is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory ...

Multiple sclerosis (MS) fatigue isn't the same as tiredness. Tiredness affects everyone after certain activities or at the end of the day. Usually, you know why you're tired, and a good night's ...

Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosisIf approved, tolebrutinib would be ...

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...

Large language model algorithms may be reliable for synthesizing large patient databases to more rapidly and accurately diagnose multiple sclerosis, according to a poster presented at ACTRIMS.

Multiple sclerosis is a disease that results when the immune system mistakenly attacks the brain and spinal cord. It affects nearly one million people in the U.S. and over 2.8 million worldwide.

A significant benefit was observed with Tysabri over Rebif in delaying SPMS disability progression when therapeutic lag was ...

Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative ...

Using 3T MRI to analyze central vein counts and distribution in white matter lesions allows investigators to distinguish multiple sclerosis from migraine pathology. Medscape Medical News ...